Terminated NA INTERVENTIONAL 3-arm NCT01909908

ECM and Blood Components for Wound Healing

Treatment of Chronic Wounds Using Extracellular Matrix-Based Devices and the Patient's Own Blood Components

Sponsor: Cook Group Incorporated

Conditions Foot Ulcer, Diabetic Ulcer Venous Ulcer

Interventions Blood Products ECM ECM in Blood Products

Updated 6 times since 2017 Last updated: Sep 28, 2016 Started: Feb 28, 2013 Primary completion: Jun 30, 2016 Completion: Sep 30, 2016

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Terminated

Slow enrollment

Other terminated trials from Cook Group Incorporated

See all terminations from Cook Group Incorporated

Other Foot Ulcer, Diabetic trials with similar outcome

Browse all Foot Ulcer, Diabetic trials

This NA trial investigates Foot Ulcer, Diabetic and Ulcer and is currently terminated or withdrawn. Cook Group Incorporated leads this study, which shows 6 recorded versions since 2013 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Status Flow

Change History

6 versions recorded

Sep 2024 — Present [monthly]

Terminated NA
Jul 2024 — Sep 2024 [monthly]

Terminated NA
Jan 2021 — Jul 2024 [monthly]

Terminated NA
Jun 2018 — Jan 2021 [monthly]

Terminated NA
Aug 2017 — Jun 2018 [monthly]

Terminated NA

▶ Show 1 earlier version

Jan 2017 — Aug 2017 [monthly]

Terminated NA

First recorded

Feb 2013

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Cook Group Incorporated

Data source: Cook Group Incorporated

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Winnipeg, Canada